Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

20:44 EST 13th February 2016 | BioPortfolio

PubMed Articles [297 Associated PubMed Articles listed on BioPortfolio]

Preeclampsia and Future Risk for Maternal Ophthalmic Complications.

Objective To investigate whether patients with a history of preeclampsia have an increased risk of long-term ophthalmic complications. Study Design A population-based study comparing the incidence...

Positive Association Between Betatrophin and Diabetic Retinopathy Risk in Type 2 Diabetes Patients.

Betatrophin is a recently identified protein that has been shown to be associated with lipid metabolism and insulin resistance. This study aimed to measure serum betatrophin concentrations in patients...

Evaluating a health video on diabetic retinopathy.

Issue addressed: Indigenous Australians are 14 times more likely than non-Indigenous Australians to develop diabetic retinopathy (DR). Blindness can be prevented in 98% of cases if DR is identified an...

Early detection of type 2 diabetes mellitus and screening for retinopathy are associated with reduced prevalence and severity of retinopathy.

To explore whether the prevalence and severity of retinopathy differ in diabetes cohorts diagnosed through screening as compared with conventional health care.

Four-port bimanual 23-gauge vitrectomy for diabetic tractional retinal detachment.

Four-port bimanual vitrectomy is a surgical technique that facilitates removal of epiretinal membranes in severe proliferative diabetic retinopathy (PDR). As the illumination is held by the assistant ...

Oral propranolol in early stages of retinopathy of prematurity.

To assess the effect of oral propranolol on the progression of early stages of retinopathy of prematurity (ROP) in very low birth weight (VLBW) infants.

Contemporary Retinal Imaging Techniques in Diabetic Retinopathy: a review.

Over the last decade, there has been an expansion of imaging modalities available to clinicians to diagnose and monitor the treatment and progression of diabetic retinopathy. Recently, advances in ima...

Protective role of sulphoraphane against vascular complications in diabetes.

Context Diabetes is a global health challenge. Although large prospective clinical trials have shown that intensive control of blood glucose or blood pressure reduces the risk for development and prog...

Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.

The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetu...

MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways.

MicroRNAs (miRNAs) are important for the proliferation of endothelial cells and have been shown to be involved in diabetic retinopathy (DR). In previous study, we found that miRNAs might play a critic...

News Articles [121 Associated News Articles listed on BioPortfolio]

Mattax Neu Prater Eye Center First to Bring Retinal OCT Angiography to Ozarks

Mattax Neu Prater Eye Center becomes the first in the Ozarks to offer AngioPlex™ OCT Angiography technology used to more easily identify the earliest signs of retinal disease. Springfield, MO (PRWEB...

Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up

Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up Eye advance online publication, February 12 2016. doi:10.1038/eye....

Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus

Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus Eye advance online publication, February 12 2016. doi:10.1038/eye.2016.13 Auth...

AKB-9778 improves underlying diabetic retinopathy in TIME-2 study

AKB-9778 alone or in combination with ranibizumab improved underlying diabetic retinopathy in eyes with and without diabetic macular edema in the TIME-2 phase 2a study, Aerpio Therapeutics announced i...

Researchers Discover Genetic Mutation Preventing Diabetes Complications

The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.Read more about Researche...

Aerpio Therapeutics Announces Presentation of Positive Results of AKB-9778 in Patients with Diabetic Retinopathy from TIME-2 Phase 2a Study

AKB-9778, a Tie2 activator, administered subcutaneously alone or in combination with Lucentis®, demonstrated ability to improve underlying diabetic retinopathy (DR) ...

Depression severity linked to chronic diabetes complications among older patients

Older adults with diabetes were more likely to report moderate or severe depression when living with chronic complications, including retinopathy, neuropathy and end-stage renal disease requiring dial...

Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Disease

LONDON, February 9, 2016 /PRNewswire/ -- European Ophthalmic Review, the peer-reviewed journal, has published an overview on AngioPlexTM optical coherence tomography angiography of the retinal microv...

Speaker delivers DRCR.net update at Angiogenesis meeting

MIAMI — Harry W. Flynn Jr., MD, discussed the newly published and continuing trials of the Diabetic Retinopathy Clinical Research Network at Angiogenesis, Exudation, and Degeneration 2016.Protocol S...

£18m Centre at NETPark to lead the way on healthcare photonics

An £18m centre designed to lead the way in the one of the most innovative and fastest-growing areas of healthcare is to be established in the North East.Healthcare photonics involves the use o...

Events [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [202 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

The purpose of this study is to assess the efficacy and safety of up to 3 intravitreal injections of ocriplasmin (0.0625mg or 0.125mg), in subjects with moderately severe to very severe no...

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Experimental data suggest that GLP-1 promote endothelial cell growth and angiogenesis which may have beneficial effects on the cardiovascular system but harmful effects on the retina . Thi...

The Relationship of Advanced Glycation Endproducts (AGEs) in the Anterior Lens Capsule to Glycemic Status and Diabetic Retinopathy: A Cross Sectional Study of Patients With and Without Type 2 Diabetes Mellitus (T2DM) Undergoing Cataract Surgery

The overall purpose of this COMIRB application is to perform a cross-sectional pilot study to aid in the design of a prospective epidemiologic study for an NIH grant application. The long ...

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study

Diabetic macular edema refers to swelling (fluid accumulation) in the center of the retina. The retina is like the film of a camera and is located in the back of the eye. This condition ca...

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

To determine the efficacy of intravitreal ranibizumab injection as adjuvant therapy in the treatment of postvitrectomy diabetic vitreous hemorrhage (PDVH) accompanied by neovascular glauco...

PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System

The aim of this study is to compare the severity of expressed pain scores in patients with PDR who underwent either PASCAL or conventional laser and to assess the association between patie...

Rainbow Extension Study

The purpose of this study is to evaluate the long term efficacy and safety of intravitreal ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy of ...

International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients - the ICV-DME Study

The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading t...

Anti-VEGF Treatment for Prevention of PDR/DME

Multiple studies have implicated vascular endothelial growth factor VEGF as a major causative factor in human eye diseases characterized by neovascularization including proliferative diabe...

The Effects of Leucine and Isoleucine on Glucose Metabolism

Diabetes is classified as an impairment of the body's ability to control blood glucose levels. Uncontrolled hyperglycemia can give rise to macrovascular (i.e., heart disease and stroke) an...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks